MedWatch

Vifor Pharma gets new CEO

In August, British industry veteran Abbas Hussain will take over the post of CEO at Vifor Pharma.

Photo: Vifor Pharma / PR

On Aug. 16, Hussain will step into the role of CEO at Vifor Pharma after Stefan Schulze has opted to resign for personal reasons, according to a Vifor Pharma press release.

Like the Danish company Pharmacosmos, Vifor Pharma focuses on iron deficiency, among other expertise areas.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs